Pre-solicitationPosted Jul 28, 2026·Responses due Aug 7, 2026

Merck Stockpile Vaccine Storage and Rotation Contract

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
493120
Value
Not stated
Solicitation
75D30126R73481
Set-aside
None stated
PSC
R799
Place
Atlanta, GA, USA
Contact
Not stated
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75D30126R73481 in this department, oldest first.

Early notice
  • Jul 23, 2026
    Pre-solicitation
    Open
  • Jul 28, 2026 · this notice
    Pre-solicitation
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (2 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (CDC OFFICE OF ACQUISITION SERVICES), same product/service code (PSC) R799.

Single-winner award sizes (3): middle half $7.1M to $159.1M, median $9.5M; range $4.8M to $308.8M.

WinnerAwardsValueLast
GENERAL DYNAMICS INFORMATION TECHNOLOGY, INC. · $GD · $42.3B1$308.8MOct 17, 2025
MERCK SHARP & DOHME LLC · $MRK · $60.1B1$9.5MSep 14, 2026
PCI PROFESSIONAL SERVICES, LLC1$4.8MMay 19, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $GD reported $42.3B revenue in FY2025. The median single-winner award in these 3 past awards, $9.5M, is under 0.1% of that. 10-K
  • $MRK reported $60.1B revenue in FY2025. The median single-winner award in these 3 past awards, $9.5M, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (4 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • $439K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 2 of the past winners are listed companies
  • 0 insider buys and 11 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.